跳至主要内容
临床试验/NCT01353430
NCT01353430招募中不适用

Characterization of Familial Myopathy and Paget Disease of Bone

University of California, Irvine1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1

研究概览

简要总结

The investigators are researching families with inherited inclusion body myopathy (IBM) and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also called IBMPFD. IBMPFD is caused by mutations in the VCP gene. Our main goal is to understand how changes in the VCP gene cause the muscle, bone and cognitive problems associated with the disease.

The investigators are collecting biological specimen such as blood and urine samples, family and medical histories, questionnaire data of patients with a personal or family history of VCP associated disease. Participants do not need to have all symptoms listed above in order to qualify. A select group of participants may be invited to travel to University of California, Irvine for a two day program of local procedures such as an MRI and bone scan.

Samples are coded to maintain confidentiality. Travel is not necessary except for families invited for additional testing.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria include all individuals with a combination of medical problems including muscle and bone disease and their family members. Because historically VCP related muscle disease has been erroneously diagnosed with the following diagnoses, therefore if these patients also have a personal or family history of bone disease they will be considered eligible for the study:
  • Muscle disorders considered include:
  • Limb Girdle Muscular Dystrophy
  • Inclusion body myopathy
  • FSH (Facioscapular muscular dystrophy) without the mutation
  • Scapuloperoneal muscular dystrophy
  • Amyotrophic Lateral Sclerosis
  • Non specific muscular dystrophy
  • Bone disorders including:
  • Paget disease of bone
  • Fibrous dysplasia
  • Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH)
  • Non-specific bone disease
  • Eligible participants must also be:
  • Subjects must to 18 years or older
  • Subjects must to able to give consent
  • Adult family members or spouses over the age of 18 of the affected individuals

排除标准

  • Under the age of
  • Individuals who report a different unrelated diagnosis will be excluded from the study. Testing to confirm different diagnoses will not be performed, instead patient will be questioned for this information and records will be obtained for confirmation of appropriate testing.
  • Those who are unable to provide consent for themselves will be excluded from participating in the study.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Virginia Kimonis

Professor

University of California, Irvine

研究点 (1)

Loading locations...

相似试验